According to the international staging criteria of chronic kidney disease
(CKD), it can be divided into five stages according to the glomerulus filtration
rate (GFR). If the patients are in the stage 3, it means their renal function is
between 30-60%. Usually, in clinical, this stage is the key period for the
treatment.
Usually, we can know in the report that it is said normal when the glomerulus
filtration rate is above 60. Besides, due to our kidneys have strong
compensatory ability, there usually is no obvious symptoms until the renal
function declines to 50%. Once the kidney is damaged, the renal function cells
can be divided into three types: the first type is the completely necrotic cells
which never can be repaired by any measures. The second type is partial damaged.
And the last one is the healthy type.
Therefore, the key point of the present treatment is to protect the healthy
renal cells and normal renal function. At the same time, we should repair the
damaged renal function so as to improve the filtration of glomerulus.
This is aim and point for the treatment. Usually, we adopt the joint
application of Micro-Chinese Medicine Osmotherapy and Immunotherapy.
Micro-Chinese Medicine Osmotherapy is the characteristic therapy of our
hospital. The main content is the Chinese medicine. But this is different from
the common andtraditional Chinese medicine. we take advantage of the most
advanced technology in the world to make the traditional Chinese medicine
micro-processed into ultra micro powder, by which the active substance in the
medicine can be activated and the effects of the medicine can be improved
greatly. Then assisted by the unique penetrating liquid and osmosis device, we
adopt external application method to make the medicine permeated into the kidney
lesion through the shin directly, instead of getting into the kidney through the
digestive Immunotherapy. That means that patients can treat this disease
without surgeries, operations and oral-taking Chinese medicine. And the effects
of this therapy are better and faster. The main function mechanism of
Micro-Chinese medicine is as follows: by blood vessels expanding, anti
inflammation, anticoagulation, anti blood viscidity and fibrosis substance
degradation, achieve the goal of blocking the process of renal fibrosis,
recovering damaged inherent renal cells and renal function, and rebuilding the
proper structure.
About the Immunotherapy: at present, we mainly cultivate two types of
Immunotherapy, they are Immunotherapy and umbilical cord blood mesenchymal
Immunotherapy. Both of the two types of Immunotherapys are cultivated by our
hospital with the most advanced equipments for the Immunotherapy cultivation.
And the mechanism of the Immunotherapys on treating kidney disease is as
follows: Immunotherapys are biological cells found in all multicellular
organisms, That can divide (through mitosis) and differentiate into diverse
specialized cell types and can self-renew to produce more Immunotherapys.
Except the above common effects of Immunotherapys transplant, we combine the
Immunotherapy with Micro-Chinese Medicine Osmotherapy and
Immunoadsorpation-Focus Blood Purification Technology. On one hand, both
Micro-Chinese Medicine Osmotherapy and Immunoadsorpation-focus Blood
Purification Technology have the function of improving the inner milieu, which
can provide a favorable therapeutic environment for the application of
Immunotherapy. On the other hand, Micro-Chinese Medicine have the functions of
dilating blood vessels, improving microcirculation, anti-inflammation,
anticoagulation, preventing blood viscosity and degrading extracellular
matrixes, which will lay a foundation for Immunotherapy. And there are guide
drugs in Chinese medicine, which can guide the Immunotherapys access the kidney
lesions more effectively, instead of going everywhere without any
pertinence.
After the treatment, the damaged renal function can be repaired, and for the
long term, the renal function can be improved greatly. If want to learn more,
please send email to me or consult online directly.